Premier destination for HCP diabetes education that addresses knowledge and practice gaps to enhance patient care
Global diabetes guideline that informs about the benefits and limitations of metabolic (bariatric) surgery for treating type 2 diabetes. Click here.
Recommendations for foot care in patients with type 2 diabetes. Click here.
2016 ADA Standards of Medical Care in Diabetes—summary recommendations and companion slides are here.
ADA Position Statement: Type 1 Diabetes Through the Lifespan – Released in 2014. Click here.
ADA 2013 Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Click here.
Updated guidelines for type 2 diabetes screening for asymptomatic adults who are overweight or obese - Released in 2015. Click here.
AHA/ADA Prevention of Cardiovascular Disease in Type 2 Diabetes - Released in 2015. Click here.
AACE diabetes management guidelines - Released in 2015. Click here.
Pharmacologic Management of Obesity – Released in 2015. Click here.
Diabetes and Pregnancy Clinical Practice Guideline – Released in 2015. Click here.
ADA/EASD Position Statement on Management of Hyperglycemia in Type 2 Diabetes – Updated in January 2015
Managing type 2 diabetes in adults - Released in 2015.
Consensus Report on Hypoglycemia and Diabetes – Released in 2013
Recommendations for Managing Newly Diagnosed Type 2 Diabetes in Children and Adolescents from the AAP, Pediatric Endocrine Society, American Academy of Family Physicians, ADA, and Academy of Nutrition and Dietetics - Released in 2013
Guideline for the Management of Overweight and Obesity in Adults -- Released in 2013
Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Update to ATP III guidelines - Released in 2103
Guideline on Lifestyle Management to Reduce Cardiovascular Risk—Released in 2013
Consensus Report on Diabetes in Older Adults - Released in 2012
Oral Medications for Type 2 Diabetes - Released in 2012
Global Guideline for Type 2 Diabetes—Released in 2012
Diabetes, Prediabetes, & Cardiovascular Disease
Any pharmacologic agent discussed is approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual manufacturer's prescribing information for use outside of the United States.
Guideline summaries created independently by Ashfield Healthcare Communications; not associated with funding via an educational grant or a promotional/commercial interest.
Sponsored by Ashfield Healthcare Communications, Lyndhurst, NJ. Copyright © 2016 Ashfield Healthcare Communications. All rights reserved.